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What is already known about this subject: Repeated cycles of electric stimulation 
inhibit cutaneous vasoconstriction to noradrenaline, but the mechanism is unknown. 
Investigating this is important because peripheral electrical stimulation is useful for 
pain modulation and appears to assist cutaneous wound healing. 
What this study adds: Intermittent, brief electrical stimulation of the forearm over a 
10-day period inhibited vasoconstriction and axon-reflex vasodilatation to 
noradrenaline, but did not affect vasoconstriction to vasopressin or axon-reflex 
vasodilatation to histamine. Thus, electrical stimulation may evoke a specific 
reduction in responsiveness to noradrenaline. 
Summary 
Aim: To investigate whether desensitization to the vasomotor effects of noradrenaline 
is a specific effect of electric stimulation. 
Methods: Three sites on the forearm of ten healthy volunteers were stimulated with 
0.2 mA direct current for two minutes twice daily for ten days. Noradrenaline and 
histamine were then displaced from ring-shaped iontophoresis chambers into two of 
the pre-treated sites and two untreated sites on the contralateral forearm. Axon-reflex 
vasodilatation was measured from the centre of the ring described by the 
iontophoresis chamber with a laser Doppler flowmeter. One or two days later, 
noradrenaline and vasopressin were introduced into pre-treated and untreated sites by 
iontophoresis, and vasoconstriction at sites of administration was measured in the 
heated forearm.   
Results: The pre-treatment blocked vasoconstriction to noradrenaline [median 
increase in flow 1%, interquartile range (I.R.) -41% to 52%; median decrease at the 
untreated site 53%, I.R. -70% to -10%; p<0.05], but did not block vasoconstriction to 
vasopressin (median decrease 42% at the untreated site and 45% at the pre-treated   3 
site). Axon-reflex vasodilatation to noradrenaline was diminished at the pre-treated 
site (median increase in flow 33%, I.R. 2% to 321%; untreated site 247%, I.R. 31% to 
1,087%; p<0.05). However, axon-reflex vasodilatation to histamine did not differ 
significantly between the pre-treated site (median increase 1,085%) and the untreated 
site (median increase 1,345%).  
Conclusions: The conditioning pre-treatment appears to evoke a specific decrease in 
responsiveness to noradrenaline. Repeated cycles of electrical stimulation may down-
regulate neural and vascular responses to noradrenaline by repetitively activating 
cutaneous sympathetic nerve fibres.   4 
Introduction 
  Local administration of noradrenaline by iontophoresis produces a dose-
dependent decrease in skin blood flow in the heated human forearm [1]. Curiously, 
however, this adrenergic vasoconstrictor response is minimal in forearm skin 
conditioned by brief, occasional administration of direct anodal current over a 4-10 
day period [2]. Investigating this effect might be of clinical interest because peripheral 
electrical stimulation is useful for pain modulation and appears to assist cutaneous 
wound healing [3, 4]. 
  At least three mechanisms could contribute to loss of adrenergic 
vasoconstriction following electrical stimulation of the skin. First, electrical 
stimulation induces the antidromic release of vasoactive neuropeptides such as 
calcitonin gene-related peptide and substance P from sensory nerve terminals [5]. 
Release of these neuropeptides from capsaicin-sensitive cutaneous nociceptors 
initiates a vasodilator response that spreads from the site of stimulation to encompass 
the terminal distribution of the stimulated neuron [6]. Persistent neurogenic 
vasodilatation between cycles of electrical stimulation might counter adrenergic 
vasoconstriction. Second, prostaglandin synthesis under the contact electrodes used 
for iontophoresis contributes to current-induced vasodilatation [7, 8]. This vasodilator 
response might also mask adrenergic vasoconstriction. Third, the electrical stimulus 
could provoke the local release of noradrenaline from sympathetic nerve terminals. 
Although this would initially oppose neurogenic vasodilatation to the electrical 
current [9], repeated electrically-evoked release of noradrenaline might down-regulate 
cutaneous vascular adrenoceptors [10], thereby inhibiting adrenergic vasoconstriction.  
The aim of the present study was to examine the effect of the conditioning pre-
treatment on vasoconstriction to noradrenaline and vasopressin, and on axon-reflex   5 
vasodilatation to noradrenaline and histamine in the skin of the human forearm. 
Selective attenuation of adrenergic responses would support the hypothesis that 
repetitive electrical stimulation promotes the desensitization of cutaneous 
adrenoceptors. Introduction of histamine into the skin of the forearm provokes a flare, 
mediated by H1 receptors, that spreads well beyond the site of stimulation [11]. A 
flare that is greater than the response to electrical stimulation alone, and that is 
inhibited by topically-applied local anaesthetic agent, also develops after the 
iontophoresis of noradrenaline in the human forearm [12]. The mechanism of this 
vasodilator response is uncertain, but may involve direct stimulation of adrenergic 
receptors in the skin. If so, electrically-provoked desensitization of these adrenergic 
receptors should attenuate the flare to noradrenaline but should not affect the flare 
provoked by histamine. To investigate these hypotheses, vascular responses to 
vasopressin, histamine and noradrenaline were examined at pre-treated and untreated 
sites in the human forearm.  
Method 
Subjects 
  The sample consisted of ten healthy volunteers (three men and seven women 
aged between 21 and 38 years) who were not taking prescription medication (apart 
from the oral contraceptive) for any medical condition. They each provided informed 
consent for the procedures, which were approved by the Murdoch University Human 
Research Ethics Committee. 
Overview of the procedures 
  After ten days of pre-treatment at three sites on the forearm, subjects 
participated in two experiments at 1-2 day intervals. The pre-treatment regime was 
maintained at the three experimental sites between the experiments. In each of the   6 
experiments described below, drugs were introduced into pre-treated and untreated 
skin by iontophoresis, and effects of the drug on skin blood flow were evaluated. 
Different iontophoresis capsules were used for each drug solution to prevent any 
inadvertent mixing of the drugs.  
Pre-treatment  
A perspex capsule with an internal chamber diameter of 20 mm was attached 
with an adhesive washer to a site on the dorsal aspect of the left or right forearm, and 
a 3 cm x 5 cm silver plate coated with conductive gel that acted as a cathode was 
attached to the upper arm. To ensure that the capsule adhered firmly and that good 
electrical contact was made, the site was shaved, if necessary, and cleaned with an 
isopropyl alcohol swab. Care was taken not to touch the skin with the razor while the 
hair was being removed. The chamber was filled with a conducting medium (0.9% 
saline) and the skin underneath the chamber was stimulated with direct anodal current 
of 0.2 mA for two minutes. The perimeter of the capsule was marked with indelible 
ink so that the capsule could be repositioned accurately when the electrical 
stimulation was repeated. The same procedure was carried out at two additional sites 
on the same forearm, separated from the other sites by at least 10 cm. Each site was 
stimulated twice per day for the next ten days. This pre-treatment sequence inhibits 
vasoconstrictor responses to noradrenaline administered by iontophoresis in the skin 
of the human forearm [2]. 
Experiment 1: axon-reflex vasodilatation to noradrenaline and histamine  
Solutions of 0.5 mM norepinephrine bitartrate (noradrenaline, Sigma, Sydney, 
Australia) and 0.5 mM histamine hydrochloride (Sigma) were prepared on the day of 
the experiment with distilled water from stock solutions at 10 mM. Fresh stock 
solutions were prepared fortnightly and stored in a refrigerator at 4
oC. Two of the pre-  7 
treated sites (selected at random) were cleaned with isopropyl alcohol, and two 
additional sites on the contralateral forearm were shaved, if necessary, and cleaned. 
An iontophoresis capsule with a ring-shaped drug solution chamber (inner diameter 
15 mm and outer diameter 19 mm) was attached to one of the prepared sites, and 
filled with the noradrenaline or histamine solution. Adhesive tape was used to form a 
waterproof seal on each side of the drug solution chamber. During each iontophoresis, 
a weak electric current repelled positively-charged noradrenaline or histamine 
molecules away from the anode into the underlying skin. For noradrenaline, a direct 
current of 350 µA was employed for 3 minutes, because the dose delivered by this 
current induces an axon reflex that is substantially greater than the axon reflex 
induced by the current itself [12]. A two-minute 100 µA direct current was used to 
introduce histamine into the skin because pilot studies indicated that the dose 
delivered by this current induced substantial axon reflex vasodilatation. The electrical 
circuit was completed with a cathode attached to the upper arm. The order of drug 
administration was counterbalanced across pre-treated and untreated sites, and was 
alternated between the left and right arms. 
  Before, during and after the iontophoreses, skin blood flow was detected with 
a wide surface area laser Doppler flow probe positioned in the centre of the ring 
described by the iontophoresis chamber, approximately 1 cm from the site of drug 
administration. Changes in skin blood flow to a depth of 1-2 mm were monitored with 
a Moor Instruments MBF3D laser Doppler flowmeter (Axminster, England). In 
addition, changes in blood flow were detected with a second laser Doppler flow probe 
positioned 10-15 cm from the sites of iontophoresis. The signals were sampled at 5 Hz 
and later averaged using Moorsoft software for two minutes before the iontophoresis, 
and between 5 and 7 minutes after the iontophoresis when vasodilatation peaked.   8 
Changes in skin blood flow after the iontophoresis were expressed as the difference in 
arbitrary units of flow and the percentage of levels recorded at the same site before the 
iontophoresis.  
Experiment 2: vasoconstriction to noradrenaline and vasopressin 
  Noradrenaline (0.5 mM) was introduced into one of the three pre-treated sites 
(selected at random) from an iontophoresis capsule with a chamber diameter of 10 
mm using a 50 µA direct current for 60 seconds. Noradrenaline was also introduced 
into an untreated site 3-5 cm away on the forearm at the same current intensity and 
duration. The dose of noradrenaline delivered by this current was expected to produce 
minor vasoconstriction at the site of administration [1]. Vasopressin was introduced 
into the second pre-treated site and an untreated site nearby. The same stimulus 
parameters were used for noradrenaline and vasopressin, to ensure that any 
nonspecific effects of iontophoresis on skin blood flow were similar at both sites. The 
electric current was also passed through a conducting medium (0.9% saline) at the 
third pre-treated site and another untreated site nearby in the same forearm, to 
delineate any nonspecific effect of iontophoresis. Laser Doppler flow probe holders 
were then attached over the sites of iontophoresis and over a reference site several cm 
away from the other sites with adhesive washers. 
To ensure that normal endogenous constrictive influences on cutaneous 
vessels were minimal, the forearm was immersed in 42
oC water for ten minutes before 
vascular measures commenced. Skin blood flow increases for around 35 minutes in 
the heated forearm before reaching an upper limit [13]. However, only 10-15 minutes 
of heating was employed in the present study because laser Doppler measures of flow 
appear to saturate before skin blood flow peaks [13]. In forearm skin heated to 42
oC 
for 5-10 minutes, vasoconstriction increases in direct proportion to the dose of   9 
noradrenaline administered by iontophoresis [1], indicating that the vasodilatation 
induced by short periods of heating is great enough to overcome floor effects that 
would otherwise obscure responses to vasoconstrictive drugs. Blood flow was 
measured via a wide diameter laser Doppler flow probe for at least 30 seconds at each 
iontophoresis site in the immersed forearm until a stable recording was obtained. 
Blood flow was also measured at the reference site with the same flow probe before 
and after blood flow had been measured at the other sites. The iontophoreses were 
then repeated at each site, this time with a 50 µA direct current for 120 seconds. The 
dose of noradrenaline delivered by this current was expected to produce moderate 
vasoconstriction at the site of administration [1]. The arm was replaced in the 42
oC 
water for 10 minutes, and blood flow was measured again at each site. Responses to 
noradrenaline and vasopressin were expressed as the difference in arbitrary units of 
flow and the percentage of levels recorded at the reference site. 
Data analysis 
  Preliminary analyses indicated that many of the score distributions departed 
from a normal bell-shaped curve. Therefore, differences between pre-treated and 
untreated sites were investigated with Wilcoxon’s matched-pairs signed-ranks test. 
The criterion of statistical significance was p<0.05. As vasoconstriction to 
noradrenaline and vasopressin did not change significantly from the first to the second 
set of iontophoreses, responses to the second set of iontophoreses are presented in this 
report. 
Results 
Experiment 1: axon-reflex vasodilatation to noradrenaline and histamine  
  Skin blood flow did not differ significantly between the pre-treated and 
untreated sites before the histamine iontophoreses [median flow at the untreated site   10 
8.5 arbitrary units (a.u.), interquartile range (I.R.) 6.4 – 18.9 a.u.; median flow at the 
pre-treated site 10.5 a.u., I.R. 8.1 – 17.4 a.u.]. Blood flow at the central recording site 
approximately 1 cm from the site of drug administration increased substantially after 
the histamine iontophoresis, both in pre-treated and untreated skin (difference 
between sites not significant) (Figures 1A and 1C). 
Skin blood flow did not differ significantly between the pre-treated and 
untreated sites before the noradrenaline iontophoreses [median flow at the untreated 
site 10.3 a.u., I.R. 7.6 – 13.1 a.u.; median flow at the pre-treated site 11.9 a.u., I.R. 8.2 
– 18.9 a.u.]. Blood flow increased at the central recording site after the noradrenaline 
iontophoresis, more so at untreated than pre-treated sites (for arbitrary units of flow, 
Wilcoxon’s Z = 2.31, p<0.05, Figure 1B; for percent change from baseline, 
Wilcoxon’s Z = 2.19, p<0.05, Figure 1D). Changes in blood flow at more distant sites 
in the forearm were minimal. 
Experiment 2: vasoconstriction to noradrenaline and vasopressin 
  Median blood flow at the reference site in the heated skin changed from 100 
a.u. to 102 a.u. during the 4-5 minute period required for measuring flow at the 
various sites (Wilcoxon’s Z = 0.0, not significant).  
In the group as a whole, vasoconstriction to vasopressin was similar at the pre-
treated and untreated sites (Figures 2B and 2E). There was some individual variation 
in the intensity of vasoconstriction to vasopressin in untreated skin. Nevertheless, 
vasoconstriction to vasopressin did not differ significantly between untreated and pre-
treated sites in six subjects with a clear vasoconstrictor response to vasopressin 
[median response in untreated skin -55 a.u. (I.R. -82 a.u. to -35 a.u.) compared with    
-37 a.u. (I.R. -75 a.u. to 28 a.u.) in pre-treated skin, Wilcoxon’s Z = 0.73, not 
significant; in addition, the median response was 55% (I.R. 79% to 36%) below   11 
reference levels in untreated skin compared with 41% below reference levels (I.R. 
80% below to 28% above reference levels) in pre-treated skin, Wilcoxon’s Z = 0.73, 
not significant].  
In contrast to vasopressin, adrenergic vasoconstriction developed at the 
untreated site in all but one subject, and was significantly greater in untreated than 
pre-treated skin (for arbitrary units of flow, Wilcoxon’s Z = 2.31, p<0.05, Figure 2C; 
for percent change from reference sites, Wilcoxon’s Z = 2.31, p<0.05, Figure 2E). 
Discussion 
  Pre-treatment of the skin of the forearm with brief cycles of electrical 
stimulation over a ten-day period produced two interesting effects. First, the pre-
treatment blocked vasoconstriction to noradrenaline, thus confirming previous 
findings [2], but did not block vasoconstriction to vasopressin. Second, the pre-
treatment reduced axon-reflex vasodilatation to noradrenaline whereas axon-reflex 
vasodilatation to histamine remained largely unchanged.  
  Drummond and Lipnicki [2] reported that skin blood flow in the heated 
forearm was 58% lower than blood flow at reference sites after the iontophoresis of 
noradrenaline; however, flow at a site pre-treated with brief cycles of electrical 
stimulation was only 7% lower than flow at reference sites. After similar procedures 
in the present experiment, the median decrease in blood flow was 53% below 
reference levels at the untreated site compared with an increase of 1% at the pre-
treated site. Thus, the conditioning pre-treatment blocked adrenergic vasoconstriction 
in both studies. The vasoconstrictive response apparently peaked at the untreated site 
because doubling the dose produced no further vasoconstriction. Although adrenergic 
vasoconstriction was minimal at the pre-treated site, vasoconstriction to vasopressin   12 
was unaffected by the pre-treatment. Thus, the conditioning pre-treatment appeared to 
evoke a specific decrease in the vascular response to noradrenaline.  
  Iontophoresis of noradrenaline triggered vasodilatation in nearby skin, both in 
the present and a previous study [12]. Topical application of local anaesthetic agent 
blocks the flare to noradrenaline, consistent with neural mediation of this response 
[12]. Houghton et al. [14] reported recently that low-dose noradrenaline infusion via 
intradermal microdialysis fibres facilitated axon-reflex vasodilatation to gradual local 
heating of the skin; conversely, adrenergic blockade inhibited axon-reflex 
vasodilatation to direct heating. However, in the absence of iontophoretic currents or 
local heating, intradermal administration of noradrenaline through microdialysis fibres 
does not induce axon-reflex vasodilatation [15]. One potential explanation for these 
findings is that an axon reflex to direct heat or iontophoretic currents disrupts 
protective barriers that normally shield adrenoceptors from adrenergic agents in the 
extracellular fluid [16, 17]. Excitation of the unshielded adrenoceptors might then 
facilitate the axon reflex initiated by heating the skin or by iontophoretic currents. 
The conditioning pre-treatment inhibited the flare to noradrenaline, consistent 
with desensitization of adrenergic receptors on the afferent limb of the axon reflex. In 
contrast to noradrenaline, responses to histamine in pre-treated skin were similar to 
(although less variable than) responses in untreated skin, at least when expressed as 
percent change from baseline. This decrease in variability may have been due to 
depletion of neuropeptide stores in sensory nerve fibres or down-regulation of 
vascular responses to these neuropeptides. The alternate possibility, that the pre-
treatment disrupted drug delivery into the skin, seems unlikely because the 
vasoconstrictor response to vasopressin was unaffected by the pre-treatment. In the 
short-term, passage of an electric current through a saline solution enhances   13 
vasoconstriction to adrenergic agents administered subsequently by iontophoresis 
[18], possibly because an axon reflex initiated by the iontophoretic current assists the 
entry of pharmacological agents into the skin.  
  Taken together, the findings suggest that repeated cycles of electrical 
stimulation down-regulate neural and vascular responses to noradrenaline. Periarterial 
nerve stimulation triggers the release of noradrenaline from adrenergic nerves and 
calcitonin gene-related peptide from capsaicin-sensitive sensory nerves [19, 20]. 
Exposure to a high concentration of adrenergic agonists desensitizes vascular smooth 
muscle to these agents by decreasing the number of post-junctional α-adrenergic 
binding sites [10]. In the present study, desensitization may have spilt over to 
adrenergic receptors that directly or indirectly excite the sensory afferents that 
mediate axon reflexes. Evidence from several sources suggests that α-adrenoceptors 
are normally present in the cell bodies of primary afferent neurons. For example, 
messenger RNA for α1-adrenoceptors was detected in the superficial dorsal horn and 
dorsal root ganglia of rats [21]. In addition, noradrenaline and the α1-adrenoceptor 
agonist phenylephrine increased the excitability of cultured dorsal root ganglion 
neurons [22, 23]. Further investigation is required to determine whether noradrenaline 
binds directly to neural adrenoceptors or stimulates sensory nerves indirectly by 
releasing nociceptive mediators such as prostaglandins or nitric oxide [24, 25]. 
Clinical implications 
Noradrenaline increases sensitivity to heat, particularly in inflamed skin [16, 
26]. Conversely, the conditioning pre-treatment inhibits thermal hyperalgesia induced 
by the topical application of capsaicin, and reduces adrenergic hyperalgesia in heat-
sensitized skin [2]. Thus, the conditioning pre-treatment could potentially be   14 
beneficial for pain control in patients with painful neuropathies associated with 
heightened adrenergic sensitivity [27, 28].  
Electrical stimulation may also accelerate the healing of chronic superficial 
wounds, in part by increasing blood flow and tissue oxygenation around the site of 
injury [4]. A reduction in adrenergic vasoconstrictor tone following brief cycles of 
electrical stimulation could facilitate the healing of ischaemic wounds. The 
persistence of axon-reflex vasodilatation to histamine, despite a reduction in 
adrenergic sensitivity, is particularly encouraging, because in the presence of an 
adequate blood supply neurogenic inflammation may assist normal healing processes 
[29]. 
Limitations and directions for future research 
  Vasodilator responses to histamine and noradrenaline were extremely variable, 
possibly because responses were expressed in relation to low levels of blood flow at 
baseline. In future studies, standardizing responses against an estimate of maximal 
flow at each site (induced by sustained local heating or sodium nitroprusside 
administration) [30-32] might reduce variability and permit more precise analysis of 
treatment effects. Delineation of dose-response relationships would also help to 
clarify treatment effects.  
Finally, the sample was small and consisted of healthy young adults, some of 
whom were taking oral contraceptives. Effects of age, gender, cardiovascular disease, 
inflammation, peripheral neuropathy and drug treatments on electrically-evoked 
release of noradrenaline in the skin, and on desensitization of responses to 
noradrenaline, require further study.   15 
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Figure legends 
Figure 1. Change in blood flow at central recording sites 1 cm distant from the site of 
administration of histamine or noradrenaline in pre-treated and untreated skin. 
Increases in blood flow after the noradrenaline iontophoreses were greater in 
untreated than pre-treated skin (p<0.05). The box-and-whisker plots in Figures 1 and 
2 represent the range of scores (whiskers), the 25
th and 75
th percentiles (the outline of 
the box represents the interquartile range), and the median (the line through the box). 
Figure 2. Vascular responses to vasopressin, noradrenaline and saline-control 
iontophoreses at pre-treated and untreated sites in the forearm. Responses after the 
second set of iontophoreses are shown, and are expressed in relation to blood flow at a 
reference site in the forearm. Decreases in blood flow after the noradrenaline 
iontophoreses were greater in untreated than pre-treated skin (p<0.05). 
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